telbivudine has been researched along with tenofovir disoproxil fumarate in 2 studies
| Studies (telbivudine) | Trials (telbivudine) | Recent Studies (post-2010) (telbivudine) | Studies (tenofovir disoproxil fumarate) | Trials (tenofovir disoproxil fumarate) | Recent Studies (post-2010) (tenofovir disoproxil fumarate) |
|---|---|---|---|---|---|
| 486 | 85 | 332 | 25 | 0 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asif, G; Butler, SD; Chu, CK; Cote, PJ; George, AL; Gerin, JL; Hurwitz, SJ; Menne, S; Narayanasamy, J; Schinazi, RF; Tennant, BC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
2 other study(ies) available for telbivudine and tenofovir disoproxil fumarate
| Article | Year |
|---|---|
Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
Topics: Administration, Oral; Animals; Antiviral Agents; Dioxolanes; DNA, Viral; Dose-Response Relationship, Drug; Guanine; Half-Life; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Injections, Intravenous; Marmota; Prodrugs; Purines; Tissue Distribution | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |